Overview

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Status:
Completed
Trial end date:
2012-09-25
Target enrollment:
Participant gender:
Summary
This study will investigate the safety, efficacy and acceptability of two new eye drop formulations compared with Refresh Tears® in patients with dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Ophthalmic Solutions
Tetrahydrozoline